Biosynth, a leading CDMO offering high-quality catalog peptides and custom peptide manufacturing services, is excited to announce its participation in the prestigious Boulder Peptide Symposium (BPS) 2023. The event is scheduled to take place from September 18th to September 21st, 2023, at the Napa Valley Marriott Hotel & Spa in Napa, California.
The Boulder Peptide Symposium is renowned as the premier conference dedicated exclusively to the advancement of pharmaceutical peptide therapeutics. This year marks an exceptional milestone as the symposium expands its horizons beyond Colorado for the first time. The picturesque Napa Valley will serve as the backdrop for this transformative event.
Attendees of BPS 2023 will have the unique opportunity to engage with prominent figures in the biotech and pharmaceutical sectors. The symposium’s distinct format provides unparalleled access to decision-makers from both established biotechnology giants and innovative start-ups. This environment fosters networking, knowledge-sharing, and collaboration that can drive the future of peptide research and development.
Biosynth is thrilled to invite all attendees to explore its offerings at Booth 13 during the symposium. With a comprehensive range of high-quality catalog peptides and expertise in custom peptide manufacturing, Biosynth stands at the forefront of peptide innovation. Whether it’s crafting intricate peptide products or addressing complex therapeutic challenges, Biosynth’s capabilities are poised to make a significant impact in the field.
Biosynth’s team looks forward to meeting you at Booth 13.
To schedule a 30-min meeting in advance please visit: Schedule Meeting at Boulder Peptide Symposium